ArticleFrontiers in psychiatry2025
Near-infrared brain imaging study of depressive disorder with liver qi stagnation syndrome before and after treatment.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Functional near-infrared spectroscopy (fNIRS) in medical research: applications, opportunities, and challenges.Chinese medicine · 2026Review
- Compromised hepatic bilirubin clearance drives depressive symptoms via regulating microglial engulfment of dendritic spines.Journal of neuroinflammation · 2026Article
- Application of functional near-infrared spectroscopy in evaluating antidepressant treatment efficacy: a review of recent evidence (2021-2026).Frontiers in psychology · 2026Review
- Advances in brain MRI for CAD-associated cognitive impairment with supplementary perspectives from traditional Chinese medicine.Frontiers in medicine · 2026Review
- Mechanistic Exploration of Shugan Jianpi Formula for Treating Triple-Negative Breast Cancer Under Chronic Stress: A Network Pharmacology-Guided Experimental Study.Drug design, development and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study is a cohort study of depressive disorder patients with liver qi stagnation syndrome specified under the theory of Integrated Chinese and Western Medicine (ICWM). They were measured hemodynamic activity, using fNIRS assessment with verbal fluency task (VFT) pre-treatment and post-treatment, to examine the neurophysiological characteristics, and to explore the impact of drug treatment on it. Methods: This study recruited patients who were diagnosed with depressive episodes according to the DSM-V diagnostic and Traditional Chinese Medicine (TCM) diagnostic criteria in the outpatient department of Yuquan Hospital Tsinghua University. 35 patients who met the criteria were recruited. All patients were treated with selective serotonin reuptake inhibitors (SSRIs) drugs. The clinical evaluation, VFT and fNIRS assessment were performed pre-treatment and post-treatment two times. After 3 months of treatment, the clinical evaluation, VFT and fNIRS assessment were performed again as a follow-up assessment for the third time. Results: There were statistically significant differences in HAMD scores between pre-treatment and follow-up assessment ( Conclusion: This indicates that the activation of the lDLPFC improved after the treatment, and this improvement can remain stable. Hemodynamic activation can reflect the changes of brain function after the one-month treatment, even before the changes of clinical symptoms in depression liver-qi stagnation syndrome. Physiological indicators like fNIRS result may better reflect the improvement of depression liver-qi stagnation syndrome than ethological indicators like HAMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.